August 20, 2024 – Canary Global

Canary Cure Advances Novel siRNA Therapeutic Targeting Obesity into In Vivo Trials

First-in-Class Gene-Targeted Approach to Promote Fat-Burning, Preserve Lean Body Mass, and Enhance Metabolic Health by Harnessing the Endocannabinoid System

Pioneering RNA Therapy

We are revolutionizing healthcare by harnessing the power of cutting-edge RNA therapies to develop and deliver innovative treatments that address the root causes of diseases. We are committed to fostering a culture of scientific excellence and collaboration to create life-changing treatments that are safe, effective, and accessible to all.

Disclaimer: Product candidates discussed on this website are in preclinical and/or investigational stages of development. They have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. The safety and efficacy of these investigational products have not been established, and they are not currently available for commercial.

Day: 20 August 2024

Canary Cure Advances Novel siRNA Therapeutic Targeting Obesity into In Vivo Trials

Quick Links

Useful Links

Quick Contact